Clinical and sociodemographic characterization of health workers affected by COVID-19
Keywords:
COVID-19, health personal, hypertension, allergic rhinitis, complications.Abstract
Introduction: The pandemic of COVID-19 has been the very high morbidity and mortality cause worldwide that has also affected the health personnel due to the nature characteristic of its work, many times under insecure conditions and with infection risk.
Objective: To characterize health workers affected by covid-19 according to clinical and sociodemographic variables.
Method: An observational, descriptive and cross-sectional study of 114 health workers with COVID-19 belonging to José Martí Pérez Teaching Polyclinic was carried out in Santiago de Cuba, in 2021. To pick up the information the database of the Hygiene and Epidemiology Department was revised and surveys were elaborated.
Results: There was a prevalence of the female sex (78.0 %), aged 30 to 59 (83.3 %). The personal history of hypertension was present in 46.5% of those affected. The loss of smell was the most frequent symptom (53.5 %). Pneumonia (14.9 %) and fatigue (37.7%) were the complication and sequel that prevailed. Doctors represented 50.0% in the occupational profile and the most frequent infection area was the polyclinic (36.8 %).
Conclusions: The clinical and sociodemographic characteristics found in health workers with COVID-19 showed that this personnel is vulnerable, reason why biosafety measures should be strictly followed.
Downloads
References
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 [citado 07/07/2020]; 395 (10223):497-506. Disponible en: http://www.sciencedirect.com/science/article/pii/S0140673620301835
3. Voloch CM, Ronaldo da Silva F, de Almeda LGP, Cardoso CC, Brustolini OJ, Gerber AL, et al. Genomic characterization of a novel SARS-CoV-2 lineage from Rìo de Janeiro, Brasil. J Virol. 2021 [citado 30/10/2021];95(10):e00119-21. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139668/
4. Organización Mundial de la Salud. Foco Técnico: Investigaciones epidemiológicas y clínicas precoces sobre la COVID-19 para una respuesta de salud pública. 2020 [citado 05/05/2020]. Disponible en: https://www.who.int/docs/default-source/coronaviruse/200223-early-investigations-one-pager-v2-spanish.pdf?sfvrsn=8aa0856_10
5. Díaz-Canel M, Núñez Jover J. Gestión gubernamental y ciencia cubana en el enfrentamiento a la COVID-19. Anales de la Academia de Ciencias de Cuba. 2020 [citado 04/05/2020];10(2). Disponible en: http://www.revistaccuba.sld.cu/index.php/revacc/article/view/881
6. Martínez L. Covid-19: Cuba entró en fase de transmisión autóctona limitada. Cubadebate. 2020 [citado 04/05/2020]. Disponible en: http://www.cubadebate.cu/noticias/2020/04/07/cuba-en-fase-de-transmision-autoctona-limitada/
7. Becerra Canales BD, Becerra Huamán D, Quintanilla Villar FL. Tension laboral y salud mental del personal sanitario en el contexto de la pandemia de Coronavirus en el Perú. Rev. cuban. med. gen. integr. 2021 [citado 10/12/2021];37(sup):e1481. Disponible en: https://revmgi.sld.cu/index.php/mgi/article/view/1481/396
8. Peñafiel León JE, Ramirez Coronell AA, Mesa Cano JC, Martínez Suárez PC. Impacto psicológico, resiliencia y afrontamiento del personal de salud durante la pandemia por COVID-19. Archivos venezolanos de Farmacología y Terapéutica. 2021 [citado 10/12/2021];40(3). Disponible en: https://www.redalyc.org/journal/559/55969712001/55969712001.pdf
9. Camacho Servín BA, Hernández Lemus E, Martínez García M. Morbimortalidad en mujeres y hombres trabajadores de la Salud afectados con COVID -19 en la Ciudad de México: un estudio transversal descriptivo. Rev. CONAMED. 2021;26(3):116-25.
10. Narro Cornelio KM, Vázquez Tirado GA. Características clínicas y epidemiológicas en pacientes con diagnóstico de COVID-19. Red de Salud Virú, marzo-mayo 2020. Rev. Cuerpo Med. HNAAA. 2020 [citado 10/12/2021];13(4). Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S2227-47312020000400372
11. Villagrán Oliva KA, Torrontegui Zazueta LA, Entzana Galindo. Características clínicas y epidemiológicas de COVID -19 en un hospital de Sinaloa, Mexico. Rev.Med UAS. 2020;10(2):65-79.
12. Chacón Benet D, Ortíz Sablón JC, Ochoa Tamayo I, Estéfano Rodríguez RM, Lorente Chacón AJ. Comportamiento de la COVID -19 en los trabajadores de la salud. Provincia de Holguín. Marzo–Junio 2020. Correo cient. méd. 2020 [citado 10/04/2023];24(3). Disponible en: https://revcocmed.sld.cu/index.php/cocmed/article/view/3739/1791
13. Sociedad Española de directivos de Salud. Documento para la atención integral al paciente post COVID -19. Madrid: SEDISA;
2020.
14. Álvarez Caballero M, Camilo Colás VM, Barceló Román M, Sánchez Rodríguez L, Batista González A. Efectividad de la auriculopuntura en el tratamiento de pacientes con hipertensión arterial. Medisan (Santiago de Cuba). 2014 [citado 10/10/2017];18(9): 1462. Disponible en: https://www.redalyc.org/pdf/3684/368445169001.pdf
15. República de Cuba. Ministerio de Salud Pública; Dirección de Registros Médicos y Estadísticas de Salud. Anuario Estadístico de Salud 2020. La Habana: MINSAP; 2021 [citado 04/08/2022]. Disponible en: https://files.sld.cu/bvscuba/files/2021/08/Anuario-Estadistico-Espa%C3%B1ol-2020-Definitivo.pdf
16. García Batista N, Torres Bermúdez J, Batista JR, Maldonado Ríos VA, Villazón Salem S, Castro Almarales RL, et al. Tratamiento de la rinitis alérgica en época de pandemia. Documento de consenso de sociedades médicas de América Latina y el Caribe. Vaccimonitor. 2022 [citado 10/04/2023];31(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2022000300144
17. Asma y COVID–19. IntraMed. 2021 [citado 10/04/2023]. Disponible en: https://www.intramed.net/contenidover.asp?contenidoid=97992
18. Gómez Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa Díaz ZM, Minder Wissmann B, et al. COVID-19 in Health–Care Workers: A living sistematic review and meta- analysis of prevence, risk factors, clinical characteristic and outcomes. Am J Epidemiol. 2021 [citado 10/04/2023];190(1):161-75. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499478/pdf/kwaa191.pdf
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
![Secimed](/templates/images/secimed.png"){kind=small}
Guidelines for authors
